Last Updated: Sep 17, 2016
- Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
Kaya Emir F, et al. Oncology research and treatment 2016 0 (9) 534-8 - Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients.
Sable Mukund, et al. International journal of surgical pathology 2016 9 - Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Kotsopoulos Joanne et al. Journal of the National Cancer Institute 2017 Jan 109(1) - Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Kishan Amar U et al. Annals of surgical oncology 2016 Sep - Insurers May Insist On Counseling Before Genetic Tests For Breast Cancer
M Andrews, Kaiser Health News, September 13, 2016 - National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China.
Lin Guigao et al. PloS one 2016 11(9) e0162361 - Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR dependent processes.
Gorbatenko Andrej, et al. The Biochemical journal 2016 9 - Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Darb-Esfahani Silvia, et al. Oncotarget 2016 9 - Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.
Deng Zhiping, et al. Journal of human genetics 2016 9 - APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.
Han Yali, et al. Oncotarget 2016 9 - Association of FGD1 polymorphisms with early-onset breast cancer.
Beasley Sarah, et al. Oncology letters 2016 9 (3) 2071-2077 - Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma.
Guo Haisheng, et al. OncoTargets and therapy 2016 0 5257-70 - Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Prodosmo Andrea, et al. Journal of experimental & clinical cancer research : CR 2016 0 (1) 135 - Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Darabi Hatef, et al. Scientific reports 2016 0 32512 - Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Lawrenson Kate, et al. Nature communications 2016 0 12675
- Human (5316)
- Pathogen (0)
- Human (474)
- Pathogen (0)
- Huamn (122)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario